nach oben

Erschienen in:

27.05.2017 | Original Article

Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors

verfasst von: Luciane Taschetto, Giselli Scaini, Hugo G. Zapelini, Ândrea C. Ramos, Giulia Strapazzon, Vanessa M. Andrade, Gislaine Z. Réus, Monique Michels, Felipe Dal-Pizzol, João Quevedo, Patrícia F. Schuck, Gustavo C. Ferreira, Emilio L. Streck

Erschienen in: Metabolic Brain Disease | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Maple Syrup Urine Disease (MSUD) is biochemically characterized by elevated levels of leucine, isoleucine and valine, as well as their corresponding transaminated branched-chain α-keto acids in tissue and biological fluids. Neurological symptoms and cerebral abnormalities, whose mechanisms are still unknown, are typical of this metabolic disorder. In the present study, we evaluated the early effects (1 h after injection) and long-term effects (15 days after injection) of a single intracerebroventricular administration of α-ketoisocaproic acid (KIC) on oxidative stress parameters and cognitive and noncognitive behaviors. Our results showed that KIC induced early and long-term effects; we found an increase in TBARS levels, protein carbonyl content and DNA damage in the hippocampus, striatum and cerebral cortex both one hour and 15 days after KIC administration. Moreover, SOD activity increased in the hippocampus and striatum one hour after injection, whereas after 15 days, SOD activity decreased only in the striatum. On the other hand, KIC significantly decreased CAT activity in the striatum one hour after injection, but 15 days after KIC administration, we found a decrease in CAT activity in the hippocampus and striatum. Finally, we showed that long-term cognitive deficits follow the oxidative damage; KIC induced impaired habituation memory and long-term memory impairment. From the biochemical and behavioral findings, it we presume that KIC provokes oxidative damage, and the persistence of brain oxidative stress is associated with long-term memory impairment and prepulse inhibition.

Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126CrossRefPubMed

Alzoubi KH, Khabour OF, Alhaidar IA, Aleisa AM, Alkadhi KA (2013) Diabetes impairs synaptic plasticity in the superior cervical ganglion: possible role for BDNF and oxidative stress. J Mol Neurosci 51:763–770. doi:10.1007/s12031-013-0061-1 CrossRefPubMed

Amaral AU, Leipnitz G, Fernandes CG, Seminotti B, Schuck PF, Wajner M (2010) Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain. Brain Res 1324:75–84. doi:10.1016/j.brainres.2010.02.018 CrossRefPubMed

Bannister JV, Calabrese L (1987) Assays for superoxide dismutase. Methods Biochem Anal 32:279–312CrossRefPubMed

Barichello T, Martins MR, Reinke A, Feier G, Ritter C, Quevedo J, Dal-Pizzol F (2005) Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med 33:221–223CrossRefPubMed

Barschak AG et al (2007) Erythrocyte glutathione peroxidase activity and plasma selenium concentration are reduced in maple syrup urine disease patients during treatment. Int J Dev Neurosci 25:335–338. doi:10.1016/j.ijdevneu.2007.05.004 CrossRefPubMed

Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR (2008a) Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem 41:317–324. doi:10.1016/j.clinbiochem.2007.11.015 CrossRefPubMed

Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR (2008b) Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab Brain Dis 23:71–80. doi:10.1007/s11011-007-9077-y CrossRefPubMed

Barschak AG et al (2009) Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Clin Biochem 42:462–466. doi:10.1016/j.clinbiochem.2008.12.005 CrossRefPubMed

Bitsios P, Giakoumaki SG, Theou K, Frangou S (2006) Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males. Neuropsychologia 44:2494–2499. doi:10.1016/j.neuropsychologia.2006.04.001 CrossRefPubMed

Borglund M, Sjoblad S, Akesson B (1989) Effect of selenium supplementation on the distribution of selenium among plasma proteins of a patient with maple syrup urine disease. Euro J Pediatr 148:767–769CrossRef

Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234–258CrossRefPubMed

Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS (2005) Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis 20:155–167CrossRefPubMed

Brown RE, Corey SC, Moore AK (1999) Differences in measures of exploration and fear in MHC-congenic C57BL/6J and B6-H-2K mice. Behav Genet 29:263–271. doi:10.1023/A:1021694307672 CrossRef

Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1971–2005

Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749–762. doi:10.1016/j.freeradbiomed.2009.12.022 CrossRefPubMedPubMedCentral

Collins AR (2004) The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26:249–261. doi:10.1385/MB:26:3:249 CrossRefPubMed

Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A (2003) Protein carbonylation in human diseases. Trends Mol Med 9:169–176CrossRefPubMed

Dancis J, Hutzler J, Snyderman SE, Cox RP (1972) Enzyme activity in classical and variant forms of maple syrup urine disease. J Pediatr 81:312–320CrossRefPubMed

de Castro VV, de Boer MA, Diligenti F, Brinco F, Mallmann F, Mello CF, Wajner M (2004) Intrahippocampal administration of the alpha-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats. Pharmacol Biochem Behav 77:183–190CrossRef

Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431CrossRefPubMed

Dugan LL, Creedon DJ, Johnson EM Jr, Holtzman DM (1997) Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 94:4086–4091CrossRefPubMedPubMedCentral

Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi EA (2001) Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 388:261–266. doi:10.1006/abbi.2001.2292 CrossRefPubMed

Fontella FU, Gassen E, Pulrolnik V, Wannmacher CM, Klein AB, Wajner M, Dutra-Filho CS (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47–54CrossRefPubMed

Funchal C et al (2002) Alpha-Ketoisocaproic acid regulates phosphorylation of intermediate filaments in postnatal rat cortical slices through ionotropic glutamatergic receptors. Brain Res Dev Brain Res 139:267–276CrossRefPubMed

Funchal C et al (2006) Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease. Neurochem Int 49:640–650. doi:10.1016/j.neuint.2006.05.007 CrossRefPubMed

Graham FK, Putnam LE, Leavitt LA (1975) Lead-stimulation effects of human cardiac orienting and blink reflexes. J Exp Psychol Hum Percept Perform 104:175–182PubMed

Halliwell B (2011) Free radicals and antioxidants - quo vadis? Trends Pharmacol Sci 32:125–130. doi:10.1016/j.tips.2010.12.002 CrossRefPubMed

Halliwell B, Gutteridge JMC (2006) Free radicals in biology and medicine vol 4. Oxford University Press, Oxford

Hazlett EA, Dawson ME, Schell AM, Nuechterlein KH (2001) Attentional stages of information processing during a continuous performance test: a startle modification analysis. Psychophysiology 38:669–677CrossRefPubMed

Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175–189CrossRefPubMed

Howell RK, Lee M (1963) Influence of alpha-ketoacids on the respiration of brain in vitro. Proc Soc Exp Biol Med 113:660–663CrossRefPubMed

Jain P, Sharma S, Sankhyan N, Gupta N, Kabra M, Gulati S (2013) Imaging in neonatal maple syrup urine disease. Indian J Pediatr 80:87–88. doi:10.1007/s12098-012-0850-5 CrossRefPubMed

Jan W, Zimmerman RA, Wang ZJ, Berry GT, Kaplan PB, Kaye EM (2003) MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 45:393–399. doi:10.1007/s00234-003-0955-7 CrossRefPubMed

Jouvet P et al (1998) Maple syrup urine disease metabolites induce apoptosis in neural cells without cytochrome c release or changes in mitochondrial membrane potential. Biochem Soc Trans 26:S341CrossRefPubMed

Jouvet P, Kozma M, Mehmet H (2000a) Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids. Ann N Y Acad Sci 926:116–121CrossRefPubMed

Jouvet P et al (2000b) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919–1932CrossRefPubMedPubMedCentral

Kinkead B, Selz KA, Owens MJ, Mandell AJ (2006) Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism. J Neurosci Methods 151:68–81. doi:10.1016/j.jneumeth.2005.07.015 CrossRefPubMed

Kirkman HN, Gaetani GF (2007) Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem Sci 32:44–50. doi:10.1016/j.tibs.2006.11.003 CrossRefPubMed

Klee D et al (2013) Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis 36:945–953. doi:10.1007/s10545-012-9582-y CrossRefPubMed

Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513–519. doi:10.1038/74994 CrossRefPubMed

Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346–357CrossRefPubMed

Lombeck I et al (1978) The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine disease. Euro J Pediatr 128:213–223CrossRef

Mattson MP, Liu D (2002) Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. NeuroMolecular Med 2:215–231. doi:10.1385/NMM:2:2:215 CrossRefPubMed

Menkes JH (1959) Maple syrup disease; isolation and identification of organic acids in the urine. Pediatrics 23:348–353PubMed

Mescka CP et al (2013) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect. Int J Dev Neurosci 31:21–24. doi:10.1016/j.ijdevneu.2012.10.109 CrossRefPubMed

Mescka CP et al (2015) L-Carnitine supplementation decreases DNA damage in treated MSUD patients. Mutat Res 775:43–47. doi:10.1016/j.mrfmmm.2015.03.008 CrossRefPubMed

Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M (2016) Oxidative stress in neurodegenerative diseases. Mol Neurobiol 53:4094–4125. doi:10.1007/s12035-015-9337-5 CrossRefPubMed

Niizuma K, Endo H, Chan PH (2009) Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 109(Suppl 1):133–138. doi:10.1111/j.1471-4159.2009.05897.x CrossRefPubMedPubMedCentral

Olivieri G, Otten U, Meier F, Baysang G, Dimitriades-Schmutz B, Muller-Spahn F, Savaskan E (2002) Oxidative stress modulates tyrosine kinase receptor a and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells. Neurol Clin Neurophysiol 2002:2–10. doi:10.1162/153840902753658329 CrossRefPubMed

Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates vol 2. Academic Press, San Diego

Perry W, Minassian A, Feifel D, Braff DL (2001) Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry 50:418–424CrossRefPubMed

Perry W, Minassian A, Lopez B, Maron L, Lincoln A (2007) Sensorimotor gating deficits in adults with autism. Biol Psychiatry 61:482–486. doi:10.1016/j.biopsych.2005.09.025 CrossRefPubMed

Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732CrossRefPubMed

Quevedo J, Vianna M, Zanatta MS, Roesler R, Izquierdo I, Jerusalinsky D, Quillfeldt JA (1997) Involvement of mechanisms dependent on NMDA receptors, nitric oxide and protein kinase a in the hippocampus but not in the caudate nucleus in memory. Behav Pharmacol 8:713–717CrossRefPubMed

Quevedo J, Vianna MR, Roesler R, de-Paris F, Izquierdo I, Rose SP (1999) Two time windows of anisomycin-induced amnesia for inhibitory avoidance training in rats: protection from amnesia by pretraining but not pre-exposure to the task apparatus. Learn Mem 6:600–607CrossRefPubMedPubMedCentral

Radi E, Formichi P, Battisti C, Federico A (2014) Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis 42(Suppl 3):S125–S152. doi:10.3233/JAD-132738 PubMed

Ribeiro CA et al (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33:114–124. doi:10.1007/s11064-007-9423-9 CrossRefPubMed

Scaini G et al (2012a) Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease. Mol Neurobiol 45:279–286. doi:10.1007/s12035-012-8243-3 CrossRefPubMed

Scaini G et al (2012b) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106:169–174. doi:10.1016/j.ymgme.2012.04.009 CrossRefPubMed

Scaini G et al (2012c) Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease. Behav Brain Res 231:92–96. doi:10.1016/j.bbr.2012.03.004 CrossRefPubMed

Scaini G et al (2013a) Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model. J Inherit Metab Dis 36:721–730. doi:10.1007/s10545-012-9549-z CrossRefPubMed

Scaini G et al (2013b) Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus. Mol Neurobiol 48:581–589. doi:10.1007/s12035-013-8447-1 CrossRefPubMed

Scaini G et al (2014) Behavioral responses in rats submitted to chronic administration of branched-chain amino acids. JIMD reports 13:159–167. doi:10.1007/8904_2013_274 CrossRefPubMed

Scaini G et al (2015) Acute Administration of Branched-Chain Amino Acids Increases the pro-BDNF/Total-BDNF ratio in the rat brain. Neurochem Res 40:885–893. doi:10.1007/s11064-015-1541-1 CrossRefPubMed

Schonberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69–75. doi:10.1016/j.ymgme.2004.01.016 CrossRefPubMed

Sgaravatti AM et al (2003) Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232–238CrossRefPubMed

Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191CrossRefPubMed

Snyderman SE, Holt LE Jr (1964) Maple syrup urine disease. J Maine Med Assoc 55:3–5PubMed

Snyderman SE, Norton PM, Roitman E, Holt LE Jr (1964) Maple syrup urine disease, with particular reference to Dietotherapy. Pediatrics 34:454–472PubMed

Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139–154CrossRefPubMed

Taketomi T, Kunishita T, Hara A, Mizushima S (1983) Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease. Jpn J Exp Med 53:109–116PubMed

Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, Dutra-Filho CS (2000) Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181:44–49CrossRefPubMed

Tice RR et al (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221CrossRefPubMed

Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15:121–135CrossRefPubMed

Tribble D, Shapira R (1983) Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease. Biochem Biophys Res Commun 114:440–446CrossRefPubMed

Vianna MR et al (2000) Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem 7:333–340CrossRefPubMedPubMedCentral

Wajner M, Vargas CR (1999) Reduction of plasma concentrations of large neutral amino acids in patients with maple syrup urine disease during crises. Arch Dis Child 80:579CrossRefPubMedPubMedCentral

Wajner M, Coelho DM, Barschak AG, Araujo PR, Pires RF, Lulhier FL, Vargas CR (2000) Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises. J Inherit Metab Dis 23:505–512CrossRefPubMed

Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427–448. doi:10.1023/B:BOLI.0000037353.13085.e2 CrossRefPubMed

Wisniewski MS et al (2016) Intracerebroventricular administration of alpha-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats. Metab Brain Dis 31:377–383. doi:10.1007/s11011-015-9768-8 CrossRefPubMed

Wu A, Ying Z, Gomez-Pinilla F (2004) The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 19:1699–1707. doi:10.1111/j.1460-9568.2004.03246.x CrossRefPubMed

Yudkoff M, Daikhin Y, Nissim I, Pleasure D, Stern J, Nissim I (1994) Inhibition of astrocyte glutamine production by alpha-ketoisocaproic acid. J Neurochem 63:1508–1515CrossRefPubMed

Zhang L, Jope RS (1999) Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells. Neurobiol Aging 20:271–278CrossRefPubMed

Zielke HR, Zielke CL, Baab PJ, Collins RM (2002) Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implication for maple syrup urine disease and phenylketonuria. Neurochem Int 40:347–354CrossRefPubMed

Zinnanti WJ et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132:903–918. doi:10.1093/brain/awp024 CrossRefPubMedPubMedCentral

Titel: Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors
verfasst von: Luciane Taschetto
Giselli Scaini
Hugo G. Zapelini
Ândrea C. Ramos
Giulia Strapazzon
Vanessa M. Andrade
Gislaine Z. Réus
Monique Michels
Felipe Dal-Pizzol
João Quevedo
Patrícia F. Schuck
Gustavo C. Ferreira
Emilio L. Streck
Publikationsdatum: 27.05.2017
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 5/2017
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-017-0035-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2017

Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I

Retinoic acid-related orphan receptor alpha (RORA) variants are associated with autism spectrum disorder

Non-alcoholic Wernicke’s encephalopathy with cortical involvement and polyneuropathy following gastrectomy

Inhibition of NF-κB activity by aminoguanidine alleviates neuroinflammation induced by hyperglycemia

DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury